ArticleDiabetes2009
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy.
Chiara Gerhardinger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it